The effectiveness of small heterodimer partner and FGF 19 levels in prediction of perinatal morbidity in intrahepatic cholestasis of pregnancy

References

• Biberoglu E, Kirbas A, Daglar K, Kara O, Karabulut E, Yakut HI, et al. 2016. Role of inflammation in intrahepatic cholestasis of pregnancy. The Journal of Obstetrics and Gynaecology Research 42:252–257.
   PubMed Web of Science ®Google Scholar
• Bicocca MJ, Sperling JD, Chauhan SP. 2018. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. European Journal of Obstetrics, Gynecology, and Reproductive Biology 231:180–187.
   PubMed Web of Science ®Google Scholar
• Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, et al. 2018. A placebo-controlled trial of bezafibrate in primary biliary cholangitis. New England Journal of Medicine 378:2171–2181.
   PubMed Web of Science ®Google Scholar
• Di Mascio D, Quist-Nelson J, Riegel M, George B, Saccon G, Brun R, et al. 2019. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine 34:1–9.
   PubMed Web of Science ®Google Scholar
• Dixon PH, Williamson C. 2016. The pathophysiology of intrahepatic cholestasis of pregnancy. Clinics and Research in Hepatology and Gastroenterology 40:141–153.
   PubMed Web of Science ®Google Scholar
• Floreani A, Gervasi MT. 2016. New insights on intrahepatic cholestasis of pregnancy. Clinics in Liver Disease 20:177–189.
   PubMed Web of Science ®Google Scholar
• Gerussi A, D'Amato D, Cristoferi L, O'Donnell SE, Carbone M, Invernizzi P. 2020. Multiple therapeutic targets in rare cholestatic liver diseases: time to redefine treatment strategies. Annals of Hepatology 19:5–16.
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Mattsson LA. 2004. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40:467–474.
   PubMed Web of Science ®Google Scholar
• Ito S, Fujimori T, Furuya A, Satoh J, Nabeshima Y, Nabeshima Y. 2005. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. The Journal of Clinical Investigation 115:2202–2208.
   PubMed Web of Science ®Google Scholar
• Jiang M, Mishu MM, Lu D, Yin X. 2018. A case control study of risk factors and neonatal outcomes of preterm birth. Taiwanese Journal of Obstetrics & Gynecology 57:814–818.
   PubMed Web of Science ®Google Scholar
• Jones H, Alpini G, Francis H. 2015. Bile acid signaling and biliary functions. Acta Pharmaceutica Sinica B 5:123–128.
   PubMed Web of Science ®Google Scholar
• Keitel V, Dröge C, Häussinger D. 2019. Targeting FXR in cholestasis. Handbook of Experimental Pharmacology 256:299–324.
   PubMedGoogle Scholar
• Kliewer SA, Mangelsdorf DJ. 2015. Bile acids as hormones: the FXR-FGF15/19 pathway. Digestive Diseases 33:327–331.
   PubMed Web of Science ®Google Scholar
• Kosters A, Karpen SJ. 2010. The role of inflammation in cholestasis: clinical and basic aspects. Seminars in Liver Disease 30:186–194.
   PubMed Web of Science ®Google Scholar
• Kuro-o M. 2008. Endocrine FGFs and Klothos: emerging concepts. Trends in Endocrinology and Metabolism 19:239–245.
   PubMed Web of Science ®Google Scholar
• Levy C, Peter JA, Nelson DR, Keach J, Petz J, Cabrera R, et al. 2011. Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Alimentary Pharmacology & Therapeutics 33:235–242.
   PubMed Web of Science ®Google Scholar
• Li L, Chen YH, Yang YY, Cong L. 2018. Effect of intrahepatic cholestasis of pregnancy on neonatal birth weight: a meta-analysis. Journal of Clinical Research in Pediatric Endocrinology 10:38–43.
   PubMed Web of Science ®Google Scholar
• Lin BC, Wang M, Blackmore C, Desnoyers LR. 2007. Liver-specific activities of FGF19 require Klotho beta. The Journal of Biological Chemistry 282:27277–27284.
   PubMed Web of Science ®Google Scholar
• Malhi H, Camilleri M. 2017. Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases. Current Opinion in Pharmacology 37:80–86.
   PubMed Web of Science ®Google Scholar
• Manzotti C, Casazza G, Stimac T, Nikolova D, Gluud C. 2019. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy. The Cochrane Database of Systematic Reviews 7:CD012546.
   PubMedGoogle Scholar
• Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. 2019. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. The Lancet 393:899–909.
   PubMed Web of Science ®Google Scholar
• Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. 2012. Visual Analogue Scale: evaluation of the instrument for the assessment of pruritus. Acta Dermato Venereologica 92:497–501.
   PubMed Web of Science ®Google Scholar
• Shahoei SH, Kim YC, Cler SJ, Ma L, Anakk S, Kemper JK, Nelson ER. 2019. Small heterodimer partner regulates dichotomous T cell expansion by macrophages. Endocrinology 160:1573–1589.
   PubMed Web of Science ®Google Scholar
• Shin DJ, Wang L. 2019. Bile acid-activated receptors: a review on FXR and other nuclear receptors. Handbook of Experimental Pharmacology 256:51–72.
   PubMedGoogle Scholar
• Tayyar AT, Tayyar A, Kozali S, Karakus R, Koroglu N, Yuksel IT, et al. 2019. Evaluation of FGF-19 and β-klotho as biomarkers in patients with intrahepatic cholestasis of pregnancy. Archives of Medical Science 15:113–119.
   PubMed Web of Science ®Google Scholar
• Trauner M, Fickert P, Stauber RE. 1999. Inflammation-induced cholestasis. Journal of Gastroenterology and Hepatology 14:946–959.
   PubMed Web of Science ®Google Scholar
• Wunsch E, Milkiewicz M, Wasik U, Trottier J, Kempińska-Podhorodecka A, Elias E, et al. 2015. Expression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the disease. Scientific Reports 5:13462.
   PubMed Web of Science ®Google Scholar
• Yuk JM, Jin HS, Jo EK. 2016. Small heterodimer partner and innate immune regulation. Endocrinology and Metabolism 31:17–24.
   Google Scholar